Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Androgen receptors help prostate cancer cells grow and resist drugs.

Finasteride may help prevent prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Seven new genetic risk areas for prostate cancer were found.

Finasteride reduces bleeding during prostate surgery.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Finasteride's effects on prostate cancer are not clear from this text.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Serum triglyceride levels are not linked to prostate cancer risk.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain natural compounds called terpenes may help prevent prostate cancer.